New York State Common Retirement Fund lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 6.3% during the 4th quarter, HoldingsChannel reports. The firm owned 37,439 shares of the biotechnology company’s stock after selling 2,500 shares during the period. New York State Common Retirement Fund’s holdings in Axon Enterprise were worth $22,251,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of the business. Public Sector Pension Investment Board boosted its position in Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after acquiring an additional 500 shares during the last quarter. CIBC Asset Management Inc lifted its stake in Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after purchasing an additional 895 shares in the last quarter. Foundations Investment Advisors LLC purchased a new position in Axon Enterprise in the 3rd quarter worth approximately $221,000. Sequoia Financial Advisors LLC boosted its holdings in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after purchasing an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the third quarter valued at approximately $814,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Wall Street Analysts Forecast Growth
AXON has been the topic of a number of analyst reports. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective on the stock. in a research report on Thursday. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. TD Cowen started coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Finally, JMP Securities boosted their target price on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a report on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $561.31.
Axon Enterprise Stock Down 5.3 %
Shares of NASDAQ AXON opened at $513.22 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business’s 50 day moving average is $619.94 and its two-hundred day moving average is $517.11. Axon Enterprise, Inc. has a 52-week low of $265.32 and a 52-week high of $715.99. The firm has a market cap of $39.13 billion, a price-to-earnings ratio of 132.62, a PEG ratio of 5.95 and a beta of 1.05.
Insider Activity
In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 2,304 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the transaction, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This trade represents a 1.76 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is currently owned by corporate insiders.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- How to Read Stock Charts for Beginners
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- How to Start Investing in Real Estate
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.